new Research Highlights Disparities in Diabetic foot Ulcer Care and the Potential of Advanced Imaging
Recent studies underscore significant racial and ethnic disparities in the management and outcomes of diabetic foot ulcers (DFUs), particularly concerning amputation risk. Emerging technologies like fluorescence imaging are showing promise in improving diagnostic accuracy and patient care, especially in diverse patient populations.
|
1 CC, et al. Association between race/ethnicity and the risk of amputation of lower extremities among Medicare beneficiaries wiht diabetic foot ulcers and diabetic foot infections: BMJ Open Diabetes Research & Care 2020;8:e001328. |
|
2 Johnson J, Johnson AR Jr, Andersen CA, et al.Skin Pigmentation Impacts the Clinical Diagnosis of Wound Infection: Imaging of Bacterial Burden to Overcome Diagnostic Limitations. J Racial Ethn health Disparities. 2024 Apr;11(2):1045-1055. |
|
3 Price N. Routine Fluorescence Imaging to Detect Wound Bacteria Reduces Antibiotic Use and Antimicrobial Dressing Expenditure While Improving Healing Rates: Retrospective Analysis of 229 Foot Ulcers. Diagnostics (Basel). 2020;10(11). |
About MolecuLight Corp.
MolecuLight Corp. is a privately owned medical imaging company that develops and manufactures the MolecuLight i:X® and DX® wound imaging devices. These are the only commercially available point-of-care imaging devices with Class II FDA-clearance for the real-time detection of elevated bacterial burden in wounds. The devices also provide accurate digital wound measurement for comprehensive wound management, supported by clinical evidence from over 100 peer-reviewed publications.
About the National medical Association (NMA)
The National Medical Association (NMA) is the largest and oldest national organization representing African American physicians and health professionals in the United States. The NMA is dedicated to improving the health of racial and ethnic minority populations through its membership, professional development, community education, advocacy, research, and partnerships.
SOURCE MolecuLight
